11thestate Posted - 13 hours ago

$ELAN stockholders filed a claim against Elanco Animal Health for hiding delays in product approvals and safety risks tied to its key products. You can join this case to be notified about potential recovery: https://11thestate.com/cases/elanco-investor-suit

Estimize Posted - 1 day ago

Wall St is expecting 0.15 EPS for $ELAN Q4 [Reporting 02/19 BMO] http://www.estimize.com/intro/elan?chart=historical&metric_name=eps&utm_co

My_Iphone_Moment Posted - 2 days ago

$ELAN seems to only do anything AH

Terrordomo80 Posted - 2 days ago

$ELAN what an absolute pos...

BeanSupreme Posted - 3 days ago

$ELAN see you later earnings pop! 🤣

Winning_calls Posted - 4 days ago

$ELAN pick me up @$14.05 😘

Rozer900 Posted - 5 days ago

$ELAN Elanco Animal Health’s dedication to improving livestock and pet care ensures its continued growth in animal health!

Minnu Posted - 1 week ago

$ELAN https://finance.yahoo.com/news/elanco-acquires-speke-contract-manufacturing-163000864.html

11thestate Posted - 1 week ago

$ELAN stockholders filed a claim against Elanco Animal Health for hiding delays in product approvals and safety risks tied to its key products. You can join this case to be notified about potential recovery: https://11thestate.com/cases/elanco-investor-suit

BeagleFish Posted - 1 week ago

$ELAN The Company just settled with the SEC today for $15 million relating to channel stuffing and related earnings management from a few years ago. https://www.sec.gov/enforcement-litigation/administrative-proceedings/33-11326-s

My_Iphone_Moment Posted - 1 week ago

$ELAN 18 next

Winning_calls Posted - 1 week ago

$ELAN 😗😗

Winning_calls Posted - 1 week ago

$ELAN 🤞🤞👆👆👆

My_Iphone_Moment Posted - 1 week ago

$ELAN dead 💩

Winning_calls Posted - 1 week ago

$ELAN pick me up @ $14.15🫴

NVDAMillionaire Posted - 1 week ago

$ELAN Elanco Animal Health (ELAN): Navigating the Pet Health and Farm Animal Landscapes with Innovative Solutions https://beyondspx.com/article/elanco-animal-health-elan-navigating-the-pet-health-and-farm-animal-landscapes-with-innovative-solutions

My_Iphone_Moment Posted - 1 week ago

$ELAN probably not meme-y enough to get the retard gains of everything else

11thestate Posted - 2 weeks ago

$ELAN stockholders filed a claim against Elanco Animal Health for hiding delays in product approvals and safety risks tied to its key products. You can join this case to be notified about potential recovery: https://11thestate.com/cases/elanco-investor-suit

Armymike1981 Posted - 2 weeks ago

$ELAN $IBRX …. Called this … and $ROOT … going 3/3 recently 🙌

d_risk Posted - 2 weeks ago

$ELAN - 10Q - New Risk Factors Alert! New risk factors include manufacturing and supply chain challenges, regulatory hurdles, cost inflation, contract manufacturer issues, and demand volatility impacting costs and operations. https://d-risk.ai/ELAN/10-Q/2024-11-07

Marcelo7 Posted - 2 weeks ago

$ELAN decent report of ELAN , but $ZTS was way better they didn't just beat but also raised guidance

OpenOutcrier Posted - 2 weeks ago

$ELAN (+3.0% pre) Elanco Non-GAAP EPS of $0.13 beats by $0.01, revenue of $1.03B in-line - SA https://ooc.bz/l/47197

Armymike1981 Posted - 2 weeks ago

$ELAN sales of zenrelia just started … this call is way more important !!! 👁️

RMAW Posted - 2 weeks ago

$ELAN Boring….. everything in-line! Nothing to see here! 🙄

DonCorleone77 Posted - 2 weeks ago

$ELAN Elanco sees Q4 adjusted EPS 13c-18c, consensus 16c Sees Q4 revenue $1B-$1.03B, consensus $1.01B. Sees Q4 adjusted EBITDA $167M-$197M. "We are encouraged by the acceleration of constant currency sales growth from 1% in 2023 to the expected 3% organic constant currency growth in 2024. We see this accelerating further to mid-single digits in 2025 with increased sales from new products and a stabilizing base driving expected growth in both pet health and farm animal," said Todd Young, CFO of Elanco. "We expect the underlying business to drive mid-single digit organic adjusted EBITDA growth in 2025 off of $875 million, reflecting our 2024 guidance midpoint of $915 million less our estimate of approximately $40 million of aqua adjusted EBITDA from 2024, inclusive of strategic investments in our key blockbuster potential launches. Ultimately, we expect adjusted EBITDA growth in the low single digits driven by an anticipated $25 million to $35 million year over year headwind from the court-supervised insolvency of a key U.K-based contract manufacturing partner. We continue to expect innovation sales of $600 million to $700 million and our net leverage to be in the high 3x to low 4x range by the end of 2025."

DonCorleone77 Posted - 2 weeks ago

$ELAN Elanco narrows FY24 adjusted EPS view to 89c-95c from 88c-96c, consensus 92c Narrows FY24 revenue view to $4.42B-$4.45B from $4.41B-$4.46B, consensus $4.43B. The company said, "The tightened 2024 revenue guidance continues to reflect 3% organic constant currency growth inclusive of higher innovation sales contribution, now expected between $420 million to $450 million for the full year, offset by lowered expectations for U.S. Pet Health parasiticides. The impact of foreign exchange rates on revenue is now expected to be a headwind of approximately $25 million. The company is updating its adjusted EBITDA guidance range to reflect expected gross margin headwinds from product mix and manufacturing performance. Offsetting the items impacting adjusted EBITDA, improved expectations for interest expense and tax are reflected in the updated adjusted EPS guidance, with no change to the midpoint of the range. To support framing of future expectations, the company estimates that in the first half of 2024 revenue of $80 million and adjusted EBITDA of approximately $40 million was directly attributable to the aqua business."

Armymike1981 Posted - 2 weeks ago

$ELAN beat baby ….

DonCorleone77 Posted - 2 weeks ago

$ELAN Elanco reports Q3 adjusted EPS 13c, consensus 12c Reports Q3 revenue $1.03B, consensus $1.03B. "Elanco's expanding portfolio supported our fifth consecutive quarter of underlying organic constant currency revenue growth in the third quarter, and we continue to expect 3% organic constant currency growth for the full year. It's exciting to see our Innovation, Portfolio and Productivity strategy come to life with new products driving growth, led by Experior(R), Adtab(TM) and Zenrelia, and we expect this growth to accelerate to mid-single digits in 2025," said Jeff Simmons, President and CEO of Elanco. "Our late-stage pipeline has largely moved into commercialization mode with the U.S. FDA approval and launch of Zenrelia, which is off to a great start in the U.S. and Brazil. Additionally, we received U.S. FDA approval for Credelio Quattro, positioning Elanco to bring positively differentiated products to the two largest pet health markets that will contribute to an expected return to growth for U.S. pet health in 2025. Finally, we continue to drive improved cash flow and deleveraging, finishing the third quarter with net leverage at 4.3x, down 1.3x compared to June 30th aided by the proceeds from the aqua divestiture and debt paydown from operations, with continued deleveraging expected in 2025."

Scanners_Free Posted - 2 weeks ago

$ELAN BEAT TOP ND BOTTOM

My_Iphone_Moment Posted - 2 weeks ago

$ELAN 10x tomorrow?